MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mou.0000000000001341

Медицинская библиотека · Current opinion in urology · 2025

Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer.

Iaxx Romain, Teyssonneau Diego, Fallaha Catherine, Grouthier Virginie, Roubaud Guilhem

СтатьяОбзорПеревод в очереди

Аннотация

PURPOSE OF REVIEW: Advanced prostate cancer (PCa) is still dependent on the androgen receptor (AR) pathway, which has led to the development of new compounds - beyond androgen receptor pathway inhibitors (ARPIs) currently used in clinical practice - and that are able to overcome acquired resistance through AR mutations, splice variants or amplifications. With these new drugs, novel toxicities occur with new challenges for both patients and physicians. This narrative review aims to report and discuss emergent and/or related adverse events associated with these new hormonal therapies.

RECENT FINDINGS: Adrenal insufficiency-like events and cardiac disorders were the main specific adverse events associated with these new hormonal therapies for advanced PCa. Different profiles of toxicities were also related to either combination of these drugs with usual ARPIs or to compounds with multiple effects on AR pathway, mainly AR antagonism.

SUMMARY: As these new treatments are still under development, physicians need to keep up-to-date with potential emerging toxicities and manage acute and long-term toxicities.

Для цитирования: Iaxx Romain, Teyssonneau Diego, Fallaha Catherine, Grouthier Virginie, Roubaud Guilhem. Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer.. Current opinion in urology. 2025. DOI: 10.1097/mou.0000000000001341.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.